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Summary
 Background We have previously reported the short-term changes in prostacyclin profi le after 
irradiation of rat cervical cord.
 Aim Present research investigated the long-term changes of prostacyclin content.
 Materials/Methods Wistar rats in groups of fi ve were irradiated with doses of 2, 4, 6, 15, 25, 30Gy and 
a single group of 25 with 35Gy X-rays. After 26 and 39 weeks, prostacyclin con-
tent was quantifi ed by 6-keto-prostaglandin-F1a (prostacyclin stabilized metabo-
lite). Specimens were stained routinely for histological studies.
 Results The 50% latent period and effective dose were 14.86±1.16 weeks and 25.66±0.54Gy 
(p<0.0001), respectively. Average ratios of 6-keto-PG-F1a for doses of 2–30Gy 
were between 78.33–12.93% and 79.48–99.96% for 26 and 39 weeks, respective-
ly. Prostacyclin level after 35Gy shows approximately a 7:1 ratio in comparison to 
the control group (p<0.002). Histopathological changes in glial and vascular tis-
sues were diagnosed and scored. Prostacyclin bimodal profi le was observed.
 Conclusions Radiation can cause complex fl uctuations of prostacyclin in association with 
marked histopathological changes.
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BACKGROUND
Radiation myelopathy is known as one of the most 
important complications of radiation in radiother-
apy of patients. Destructive changes of the white 
matter and other nervous tissues are the major his-
topathological aspects. Dose response curves for 
treatment of malignancies distinctly show a strict 
margin between virtual 100% tumoricidal dose and 
neurotoxicity occurrence in spinal cord as a normal 
tissue [1]. It was shown that a single dose of 35Gy 
X-ray to the spinal cord can cause limb paralysis in 
rat models with a latency of 19.0±0.3 weeks [2].
Different types and methods of irradiation have 
been listed for different strains of animals, indi-
cating dose dependency, latency, relative biologi-
cal effectiveness (RBE), histopathology and patho-
genesis of radiation myelopathy [3]. Recently we 
reported the short-term changes of prostacyclin 
secretory profi le after various irradiation doses 
[4]. Histological observations showed that radi-
ation with doses of a few Gy or more in excess of 
the tolerance level induces more or less uniform 
histological changes [1,5,6].
AIM
Based on vascular theory it is postulated that en-
dothelial morphologic changes are associated 
with changes in prostaglandins, including pros-
tacyclin, which plays a major role in haemody-
namic alterations. Our short-term study showed 
fl uctuations in the concentration of prostacyc-
lin early after irradiation [4]. The authors stud-
ied late histopathology and enzymatic changes 
after doses of 2–35Gy.
MATERIALS AND METHODS
Animals and irradiation
Male Wistar rats weighing 150–200g were fi xed 
on a jig under gentle anaesthesia. The C1–T2 
segment of the spine was irradiated through two 
parallel opposed ports with an orthovoltage ma-
chine (200kVp, 1.5mmCu HVL, focal skin dis-
tance 25cm) at a dose rate of 1.53Gy/min at the 
depth of the spinal cord. Doses of 2, 4, 6, 15, 25 
and 30Gy were administered using a circular 
3.0cm diameter localizator [7]. One group of an-
imals (25 rats) was irradiated with a dose of 35Gy 
for evaluation of survival rate and to produce the 
clinical manifestation of radiation myelopathy. 
Five rats were included in each dose group in 
addition to the age-matched control group. The 
animals were sacrifi ced chronologically at fi ve 
time points of 24 hours, 2, 13, 26 and 39 weeks 
post-irradiation. Rats irradiated with 35Gy were 
followed for symptoms of radiation myelopathy 
to get radiobiological data on latent symptoms 
and lethal dose.
Sample preparations
Following decapitation under ether anaesthe-
sia, rats’ neck regions were opened posteriorly 
and the spinal cord was removed after laminec-
tomy. Then the spinal cord was cut rapidly and 
segmented into three pieces for enzyme immu-
noassay (EIA) and histopathological studies with 
transmission electron and light microscopes.
Measurement of spinal cord PGI2
Spinal cord samples were analyzed for prostag-
landin I2 (PGI2 or prostacyclin) concentration 
by enzyme immunoassay kit (Cayman Chemical 
Co.). For this purpose, samples were homoge-
nized with weight proportion of 0.1M perchlo-
ric acid and centrifuged at 4°C for 10 minutes 
at 3000rpm. Then 100–150μl supernatant was re-
moved for dilution (1:5 and 1:10) and poured 
into a 96 well EIA kit. This kit measures 6-keto 
prostaglandin F1a (6-keto PGF1a), the main 
metabolic product of PGI2. The concentration 
of 6-keto PGF1a is directly proportional to PGI2. 
Data of 6-keto PGF1a concentrations were nor-
malized in the form of the percent of the com-
parative control groups. Changes in PGI2 concen-
tration were plotted against time and irradiation 
dose using Sigma-Plot version 8.
Histopathologic study
The samples were studied histopathologically for 
cellular and subcellular changes using electron 
(TEM) and light microscopes. Preparation of sam-
ples for the light microscope followed the routine 
procedure of fi xation, embedding, cutting (4μm 
thick) and staining. TEM preparation consisted of 
fi xation, embedding, semithin formation, griding/
grinding and toluiden blue staining. Examination 
was done under appropriate magnifi cation to ob-
serve morphological changes in endothelial cells.
Actuarial analysis was carried out on survival 
data. Quantifi cation of histologic changes was 
scored based on one to three pluses in compari-
son to the age-matched control group. We used 
Student’s t-test for comparison of histopathologic 
and PGI2 concentrations between irradiated and 
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control groups. Spearman’s test was also used to 
evaluate the correlativity between PGI2 and his-
topathological changes.
RESULTS
Survival data on the irradiated rats are shown 
in Figure 1. For the 35Gy group, the 50% latent 
period (LP50) and mean latency period were 
14.9±1.2 and 14.2±0.9 weeks (95% confi dence 
limit 12.3–16.1 weeks), respectively. The ob-
tained LP100 was 20 weeks post-irradiation. Dose 
response curve based on these fi ndings is plot-
ted in Figure 2. Effective dose of 50% (ED50), 
which is the radiation dose that produces radia-
tion myelopathy in 50% of rats, was found to be 
25.7±2Gy within the 95% confi dence interval of 
24.6 and 26.7Gy.
Prostacyclin changes
Prostacyclin level in animals irradiated with 35Gy 
at the time of induction of paralysis and just prior 
to death showed a steep increase in comparison 
to corresponding control rats (approx. 7:1 with 
p<0.002, not shown). After 26 weeks of irradia-
tion, overall prostacyclin concentrations changed 
little with radiation dose. In contrast to a signifi -
cant decrease in PGI2 levels at 4 and 6Gy, a signifi -
cant increase was observed at 25 and 30Gy. Details 
of PGI2 changes after different time points are 
shown in Figure 3A. Initially a positive part of this 
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Figure 3. Profi le of PGI2 changes in long-term study: (A) Detailed 
presentation of time-wise profi le of prostacyclin changes (not 
scaled); this diagram shows concentration ratios as defi ned by 
PGI2 (irradiated)/PGI2 (age-matched control), and means ±SE are 
shown as a percentage at confi dence limit of 95%. Dots indicate 
mean value of PGI2 at each time point. (B) 3D profi le of prostacyclin 
changes as a function of time and dose.
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Gaussian curve is seen at dose of 2Gy (p=0.07), 
decreasing at dose of 4Gy (p=0.01). At dose of 
6Gy it shows a concentration not very different 
from control (p=0.007). In the high dose region 
there is an increase after 25 and 30Gy (p=0.004 
and 0.05, respectively). After 39 weeks of irradi-
ation, prostacyclin concentration decreased sig-
nifi cantly in the low dose region of 2, 4 and 6Gy 
from 78.4% to 93.3% of control (p=0.001, 0.002 
and 0.04, respectively). In the high dose region 
the decrease was signifi cant after 15Gy (p=0.004) 
but it was not signifi cant in the 25 and 30Gy ir-
radiated groups (Figure 3A). Overall changes in 
PGI2 concentration in different time and irradia-
tion dose are shown in Figure 3B. A double-peak 
action of prostacyclin response to irradiation was 
seen after 13 weeks in both low and high dose re-
gions, which may indicate bi-modal parameters 
contributing to radiation myelopathy.
Histopathological changes
Different kinds of pathologic evidence were ob-
served which are well established as signs of radi-
ation-induced myelopathy. They included severe 
demyelination, white and grey matter atrophy, 
necrosis accompanied by atrophy, gliosis, and 
vasculopathy consisting of vascular rupture and 
haemorrhage. The incidence of histopathological 
lesions was both dose- and time-dependent. Sub-
structural changes were observed even at a dose 
lower than 6Gy. However, we observed rats with 
clinical manifestation of radiation myelopathy af-
ter 25Gy. They showed paralysis of limbs and se-
vere urine discontinuity and were sacrifi ced just 
prior to death after 26–28 weeks post-irradiation. 
In these animals necrotic and atrophic changes in 
spinal cord specimens were observed. The most 
apparent pattern after 26 weeks was an increased 
density of vessels mimicking revascularization at 
the irradiated volume (Figure 4A).
Findings after 39 weeks were similar to the fi nd-
ings after 26 weeks but more intense. Severe 
multiple necrotic areas were seen in sections ob-
tained from irradiated rat cervical spinal cord af-
ter 25Gy. Fibrin deposition and replaced colla-
gen fi bres as fi brosis were seen in the interstitial 
spaces (Figure 4A).
Animals irradiated with a dose of 35Gy were ex-
amined histologically just prior to sacrifi ce for 
symptoms of radiation myelopathy. Marked path-
ological changes both in vascular and white mat-
ter parenchyma consisting of vascular rupture, 
wall thickening, severe necrosis, demyelination 
and glial proliferation were observed and are 
shown in Figure 4C.
Histopathological changes revealed with both 
light microscope and TEM are listed in Table 1. 
Changes encountered with TEM are at the level of 
the vascular endothelial cells. Photomicrographs 
were obtained at different times post-irradiation 
with different doses (Figure 5). They show chang-
es at the subcellular level including nuclear mem-
brane, cytoplasmic and basal cell membranes, and 
also alterations in endothelial cell organelles.
DISCUSSION
Animals exposed to single doses ≤15Gy (i.e. 2, 
4, 6 and 15Gy) did not reveal any specifi c clini-
cal manifestation of radiation myelopathy. After 
doses >15Gy the probability and also the severi-
ty of radiation myelopathy increases. Our results 
are similar to the results of other reported exper-
imental studies which have used different types 
of radiation [8–11]. The latency observed in our 
study is about 4 weeks shorter than the report of 
Hopewell et al. 1987 [12]. A similar discrepan-
cy was also reported by Okeda et al. 1998 [10]. 
It may have been caused by the greater volume 
of irradiated spinal cord which may decrease the 
latency [13,14].
Similar results of histopathology and radiobiology 
were shown in the study on the effects of a carbon 
ion beam on the thoracic spinal cord by Shinobu 
and Okeda 2001 [6]. The ED50 for hind-limb pa-
ralysis derived from the dose-response curve was 
18.5Gy and the RBE was 1.38. The equivalent dose 
of the X-ray beam was 25.5Gy and they found that 
67% of animals at 20Gy and 100% of animals at 
25 and 30Gy showed hind-limb paralysis, which 
is identical to our results, but at 16–20 weeks af-
ter irradiation [10].
Substantial data suggest that the prostanoids are 
particularly important in inhibiting smooth mus-
cle cell proliferation, preserving tissue viabili-
ty and organ function in experimental models 
of ischaemia. Ischaemic tissues are subjected to 
decreased oxygen tension (hypoxia), decreased 
blood fl ow, accumulation of metabolites, and pa-
renchymal cell damage. The changes of prostacy-
clin against various damaging agents were stud-
ied in vitro and in vivo. There are two target cell 
populations involved in radiation myelopathy: I) 
vascular endothelial cells and II) glial cells (es-
pecially oligodendrocytes) and prostacyclin may 
originate from both cell types [3,15,16].
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According to the present fi ndings, low-dose irra-
diation that is insuffi cient for the induction of 
a white matter lesion may still induce a vascular 
lesion, possibly because of the difference in ra-
diosensitivity between vascular endothelium and 
neuro-glial cells [6]. It was reported that vascular 
changes are not necessarily accompanied by mor-
phological endothelial alterations. In fact, some 
of the changes may be degenerative changes re-
lated to injury from infl ammation induced by 
radiation such as rupture of vessel walls, dilata-
tion and infi ltration of blood cells. Intra-vascular 
Figure 4. Some of the histopathological changes of white matter showing after H&E staining: (A) vascularization and/or increase in 
vascular density was prominent after 15Gy 26 weeks post-irradiation (×400), (B) congestion and gliosis after dose of 4Gy 13 weeks after 
irradiation (×100), (C) malacia after 25Gy 39 weeks after irradiation (×400), same manifestation of myelopathy was also seen in the 
group of 35Gy, and (D) spinal cord with deformed pattern and huge glioma after 35Gy of X-ray dose (×40).
A
B
C
D
White matter parenchyma Vascular changes Ultra-microscopic changesin endothelial cells
– White matter necrosis,
– Gliosis,
– Myelin sheath irregularities
– Demyelination of nerve fi bre
– Atrophy
– Vascular rupture and collapse,
– Vascular density variation,
– Thrombo-emboli formation,
– Blood cell infi ltration (haemorrhage)
–  Cytoplasmic and basal cell membrane 
irregularities
– Organelle morphological pattern
– Vesiculation
– Increase in number of lysosomes
– Auto lysosome formation
–  Degeneration of mitochondria (Ballooned 
cristae)
– Dilatation of endoplasmic reticulum
Table 1. Microscopic and ultra-microscopic histopathological changes in white matter parenchyma and vascularity in rat cervical spinal 
cord observed (24 hours–39 weeks) after irradiation.
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haemodynamic load can be deteriorated second-
ary to infl ammation [17,18]. However, recently 
a dose-dependent loss of endothelial cells in rat 
cervical spinal cord at 24 hours after X-ray inter-
action was reported [19].
We found related injury from radiation-induced 
myelopathy such as blood vessels plugged with 
erythrocytes in and around the destroyed vessels, 
which may support the idea of changes in blood 
fl ow and endothelial surfaces. We also observed 
irregularities in the thickness of endothelial cell 
membrane (basement and cytoplasmic) with in-
creased numbers of intracellular organelles, par-
ticularly vesicles early after irradiation, endoplas-
mic reticulum and degeneration of mitochondrial 
architecture (Figure 5).
Our chronological short- and long-term results 
further suggest that the response of the vascular 
tissues to radiation occurs prior to that of the 
nervous tissues of the spinal cord. Tissue dam-
age is not the sum of cellular damage but an in-
dependent response of a highly structured tissue 
architecture and the most responsive substruc-
ture in the endothelial cell components. In addi-
tion, the response of the vascular system to radi-
ation can be determined by the response of the 
endothelial cells, because the endothelial cells are 
introduced as the most radiosensitive among the 
cells constituting the vessel wall [6,18].
The pathological fi ndings of radiation myelopa-
thy are almost always confi ned to the damage of 
white matter and its vasculature [3,20]. Recently 
it has been suggested that radiation may alter the 
secretory profi le of mediators, which can cause 
an infl ammatory response, cellular proliferation, 
and cellular injury in the CNS [17,21]. Response 
of prostacyclin secretion to radiation should be 
considered in terms of its sensitivity to irradiation 
dose and kinetics. Finding out the existence of 
any relation between prostacyclin changes and 
induction of radiation toxicity needs to be based 
on knowledge of the physiologic effect of pros-
tacyclin on the spinal cord [22].
Our previous report indicated that prostacyclin 
content decreased at 24 hours and 2 weeks post-ir-
radiation followed by an increase at 13 weeks post 
irradiation [4]. In the present study we observed 
that the level of prostacyclin again decreased at 
26 and 39 weeks after irradiation. Overall change 
in the profi le of prostacyclin as a function of time 
has a bell shape. Change of prostacyclin as a func-
tion of time and dose is double-peaked (Figure 
3A). This may be explained at the vascular level, 
since ionizing radiation stimulates the release of 
free arachidonic acid from membrane phosphol-
ipids through activation of phospholipases. This 
can cause an abrupt increase in the level of free 
arachidonic acid in the extra-cellular space and 
may induce a transient disruption of microvessel 
permeability measured in the spinal cord of irra-
diated rats. This may also confi rm an earlier study 
of the effects of free radicals on inactivation of cy-
clo-oxygenase and prostacyclin synthase enzymes 
[21,22]. The steep down fl uctuations in our study 
may be either secondary to exhaustion of the en-
dogenous substrate or due to reduction in the activ-
ity of enzymes involved in prostaglandin synthesis. 
Late effects after low and high doses of irradiation 
showed a decrease in the concentration of prosta-
cyclin compared to the age-matched control val-
ues. This type of unsteady dose dependency may 
be due to responses of different cell populations 
with different radiation responsiveness.
CONCLUSIONS
In summary, prostacyclin synthesis shows fl uctu-
ation with radiation dose and time. Very low ra-
diation doses mainly affect endothelial cell func-
tions, while neuroglial tissues are more resistant. 
High radiation doses affect mostly neuroglial tis-
sues, inhibiting normal proliferation and differ-
entiation. Low radiation doses of 2–6Gy increase 
production of prostacyclin at early times after ir-
radiation. Single high doses of radiation show 
more complex fl uctuations of prostacyclin in as-
sociation with marked histopathological changes 
in neuroglial tissues of the spinal cord. Clearly it 
Figure 5. Transmission electron microscope images from rat spinal 
cord specimens: (A) Basal cell membrane detachment from the 
vessel wall (arrow) and deformed intracellular organelles (arrow 
head) are seen at 2Gy irradiation dose after 2 weeks (×12000), 
and (B) Mitochondrial destructive changes such as swelling 
and ballooned internal cristae (irreversible injury; arrows) with 
association of endoplasmic reticulum dilatation (arrows) at 30Gy 
(×30000) after 2 weeks are shown.
A B
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can be postulated that induction of prostacyclin 
at certain times may assist the body to overcome 
late effects of radiation.
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